Tyligand Tsn1611 First Dosing: Phase 1/2 Kras G12D Inhibitor Trial
24 May 2024 //
PR NEWSWIRE
Context & Tyligand Bioscience Reach ONA-XR Manufacturing Optimization Milestone
25 Aug 2021 //
GLOBENEWSWIRE
24 May 2024 //
PR NEWSWIRE
25 Aug 2021 //
GLOBENEWSWIRE